News & Events

News April 14, 2021

BrainsWay Announces 100,000 Patients Treated with Deep Transcranial Magnetic Stimulation (Deep TMS)

The FDA cleared technology is a noninvasive treatment for depression, OCD, and smoking addiction CRESSKILL,...

News March 24, 2021

BrainsWay Reports Fourth Quarter and Full-Year 2020 Financial Results and Operational Highlights

Conference call to be held tomorrow, March 25, 2021, at 8:30 AM ET CRESSKILL, N.J. and JERUSALEM, Israel,...

News March 11, 2021

BrainsWay to Report Fourth Quarter and Full Year 2020 Financial Results on March 25, 2021

CRESSKILL, N.J., March 11, 2020 – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the...

Events August 13, 2020

Wauwatosa, Wisconsin

Network with BrainsWay Providers in Wauwatosa, WI Copy

Dr. Hong Yin of New Frontiers Psychiatry & TMS in Milwaukee, WI will be speaking about her success...

Events July 25 - July 27, 2020

Las Vegas, Nevada

Meet BrainsWay® Virtually at Psych Congress – Elevate

BrainsWay is participating in Elevate by Psych Congress Virtual Experience through July 25 -27. The conference...

Events July 31 - August 2, 2020

Seattle, Washington

Meet BrainsWay® Virtually at the Annual IOCDF Conference

BrainsWay is participating in the Online OCD Conference through July 31 – August 2. The first event...

In the media March 23, 2021

(Interview) BrainsWay Aims to Treat COVID-Caused Depression by “Jumpstarting” Brain

BrainsWay CEO Christopher von Jako discusses how Deep TMS is used to treat neurological conditions such...

In the media February 19, 2021

Practical Applications and Uses of Deep TMS for Treating Individuals with OCD

Commentary provided by Dr. Muir and Dr. Vidrine offers in-depth insight around Deep TMS as an effective,...

In the media February 8, 2021

Rate of Depression Growing During COVID-19, BrainsWay CEO Discusses Importance and Effectiveness of Deep TMS Treatment

BrainsWay CEO Christopher von Jako outlines the importance on how informing the public on Deep TMS as...